Binetrakin

DB12182InvestigationalProtein Based Therapies

Binetrakin has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, Non-Hodgkin's Lymphoma (NHL), Myelodysplastic Syndrome (MDS), and Leukemia, Acute Myelogenous (AML), among others.

Mechanism: Pharmacologically active on Interleukin-4 receptor subunit alpha
Curator reviewed
Also known as: IL-4 · Interleukin 4 (human) · Interleukin 4 human · Interleukin-4 · Interleukin-4 (human; nonglycosylated)

Resolves to

Compound

UNII751635Z921CAS207137-56-2

Clinical / RWD

RxNorm1426682

Targets

P24394IL4R

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

39Drug interactionsStructured to mechanism, not free text

13Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Binetrakin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account